New drug could replace current standard for treating brain cancer
Glioblastoma (GBM) is a WHO grade IV brain tumor with dismal prognosis. Although post-surgical radiation…
Glioblastoma (GBM) is a WHO grade IV brain tumor with dismal prognosis. Although post-surgical radiation…
Spanish researchers have identified a range of genetic alterations in glioma brain cancers that will…
The final results of a phase 1/2 study of a therapy in recurrent glioblastoma multiforme…
Clinical-stage bio company, Onxeo, has announced that the first patients have been enrolled and treated…
According to researchers, a study at Tel Aviv University in Israel effectively eradicated glioblastoma, a…
The French company CarThera has teamed up with the US firm Kiyatec to study the…
A technique combining a blood test with artificial intelligence (AI), developed by the UK company…